-
282022.01
SCM Life Science, Introduction of diabetes treatments from bio-venture..
SCM Life Science (CEO Lee Byung-gun), a development company specializing in cell therapy, announced on the 1st that it ..
-
282022.01
SCM Life Science, equity investment in U.S. bio-venture Vita Theraputi..
SCM Life Science (CEO Lee Byung-gun), a development company specializing in cell therapy, announced on the 30th that it..
-
282022.01
SCM Life Science, enters the global Cosmetic market... Bonotox Japan a..
SCM Life Science, a company specializing in cell therapy (Scm Life Science, CEO Lee Byung-gun. KOSDAQ 298060) announced..
-
282022.01
SCM Life Science, Patent registration for a composition for enhancing ..
SCM Life Science (SCM Life Science. KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, announce..
-
282022.01
SCM Life Science, Acquired patents related to the treatment of graft-v..
SCM Life Science, a company specializing in cell therapy (SCM Life Science, CEO Lee Byung-gun. KOSDAQ 298060) announced..
-
282022.01
Clinical results of SCM Life Science atopic dermatitis homogeneous ste..
SCM Life Science (SCM Life Science, 298060, CEO Lee Byung-gun), a company specializing in research and development of c..
-
282022.01
SCM Life Science, Pharmaceutical composition for stem cell-derived hai..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun) announced on the 11th that they has obtained a C..
-
282022.01
SCM Life Science, Patent for pancreatitis stem cell therapy. Establish..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, announce..
-
282022.01
SCM Life Science, Incheon City's "Global IP Star Company Selectio..
SCM Life Science (SCM Life Science, KOSDAQ 298060, CEO Lee Byung-gun), a company specializing in cell therapy, announce..